Cephalalgia

🚨 Our new paper is published in @JCephalalgia! 🧠 We discuss the importance of including #POTS and #dysautonomia more broadly in the differential diagnosis of chronic dizziness that neurologists often encounter, especially in patients with #migraine. 🧠 A subset of patients with chronic dizziness or chronic migraine are deemed treatment-refractory when they have not responded to treatment of PPPD or #migraine. 🧠 In many of these patients, etiology may be an undiagnosed and untreated #autonomic disorder. 👇 Read here: journals.sagepub.com/doi/10.1177/03… @ihs_official @AANmember @Jacobs_Med_UB @NinaRiggins @Dysautonomia

Over 1 billion people globally suffer from migraines. Find the newest research and recommended treatments from journals like @JCephalalgia on the Neuroscience hub. Explore now: ow.ly/jcbK50Yk7U7 #Migraines #Neuroscience

Deadline approaching! Submit your original research to the Jes Olesen Awards for the Advancement of Headache Medicine. 🏆 Clinical & Basic Science Awards 💶 €10,000 each 📅 Deadline: 28 March 2026 Learn more and submit: ow.ly/kkzP50Ytvp3 @JCephalalgia @ihs_official

WHO's essential medicines list: Additions for migraine and cluster headache journals.sagepub.com/doi/10.1177/03… #hvhebron #neuro [Text complet] @JCephalalgia

Tune into this interview with Cephalalgia’s newest Editor’s Choice article author & learn about the connection between complex regional pain and migraine. Watch now: ow.ly/Qx0Z50Yhk2M @JCephalalgia @ihs_official

新しい不眠症治療薬のダリドレキサント（クービビック®︎）💊 「慢性片頭痛+慢性不眠」患者さんに投与 →不眠は良くなった😀 →でも頭痛は良くならなかった😣 やはりオレキシン系は、頭痛への直接的な改善効果はなかなか結果が出ないですね。 もちろん、不眠症治療薬としては重宝すべき素晴らしいお薬です😌

New in Cephalalgia Reports! This study offers evidence of the efectiveness of Galcanezumab in real life for the preventive treatment of episodic and chronic migraine, including an impact on psychiatric variables, contributing to daily practice and treatment guidelines journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! After market entry of CGRP mAbs, newly diagnosed patients with migraine initiated and cycled through preventative migraine medications more rapidly than those diagnosed in earlier years. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! CT-guided Gasserian ganglion injection may be a minimally invasive option for elderly or medically refractory trigeminal neuralgia patients unsuitable for surgery, with preliminary evidence of symptomatic benefit and acceptable safety. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! The clinical reasoning behind the interpretation of the findings of the assessment of migraine patients is described, using three migraine patients with different clinical presentation and individualised interventions • Individualized physiotherapy treatments can be safely delivered to patients with migraine. • The therapeutic benefit of physiotherapy interventions depends on the clinical reasoning and the individualization of the treatments, including education and lifestyle management. • Manual therapy and exercises can be used to either target cervical musculoskeletal impairments related to a CMD or improve cervical hypersensitivity through pain modulation. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! Many women with enlarged breast tissue have frequent headaches. After breast reduction, this study showed that most saw headaches, neck pain, and sleep apnea risk improve—but surgery isn’t a guaranteed treatment. More research is needed. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! In patients with chronic migraine and chronic insomnia, daridorexant improved sleep quality, but not headache frequency. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience @juliopascualg

New in Cephalalgia Reports! In daily practice, management of trigeminal traumatic neuropathic pain is a challenge. • The use of perineural botulinum toxin may be useful in the management of neuropathic pain. • This study presents the first report of perineural botulinum toxin injection with ultrasound guidance in the trigeminal innervation for the management of post-traumatic pain. • Traumatic craniofacial pain of trigeminal origin may improve with the application of botulinum toxin. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! Specialist workforce shortage: The surveyed Caribbean islands reported very few practicing neurologists, with virtually none having fellowship training in migraine/headaches. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

We are pleased to announce and congratulate the authors on their paper, “Migraine as a primary care-sensitive condition: Building pathways to accessible care” which has been selected as the Editor’s Choice for the February issue of Cephalalgia. @Simona_Sacco_ This recognition is reserved for papers that contribute valuable insights and advance our understanding and treatment of headache disorders. .......................... Migraine meets internationally established criteria for classification as a Primary Care-Sensitive Condition (PCSC), supporting early intervention to reduce avoidable hospitalizations and improve patient outcomes. • The absence of migraine from PCSC classifications perpetuates gaps in public health policies and delays the implementation of effective care models. • Recognizing migraine as a PCSC can increase its visibility in public health agendas and drive the development of structured, equitable, and cost-effective care pathways. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience @ramiburstein @mariofpperes

New in Cephalalgia! Migraine meets internationally established criteria for classification as a Primary Care-Sensitive Condition (PCSC), supporting early intervention to reduce avoidable hospitalizations and improve patient outcomes. • The absence of migraine from PCSC classifications perpetuates gaps in public health policies and delays the implementation of effective care models. • Recognizing migraine as a PCSC can increase its visibility in public health agendas and drive the development of structured, equitable, and cost-effective care pathways. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! Migraine is a leading cause of disability in Eastern Europe. This regional study (Moldova, Ukraine, Romania, Serbia) shows big gaps in diagnosis, limited access to modern therapies, and low awareness. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience

New in Cephalalgia Reports! This real-world matched control study (n=37,054) found that people with migraine had significantly higher rates of certain comorbidities and significantly higher healthcare resource utilization compared to controls. journals.sagepub.com/doi/10.1177/25… #migraine #headache #brain #pain #neurology #neuroscience @MatanyaTirosh @ShVinker

New in Cephalalgia! While chronic dizziness has a wide differential diagnosis, three common neurologic etiologies need to be considered in an outpatient evaluation: vestibular migraine, persistent postural-perceptual dizziness and dysautonomia/Postural Orthostatic Tachycardia Syndrome. Dysautonomia is a common cause of chronic dizziness. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience @dysclinic

New in Cephalalgia! There is a compelling argument for the inclusion of Solitary Pontine Lesion–Related Trigeminal Neuralgia as a distinct subgroup within Secondary Trigeminal Neuralgia in ICHD-4 journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience